OTCMKTS:KVPHQ - Lumara Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.0080
Today's RangeN/A
52-Week Range$0.02 - $0.82
Average Volume3.52 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
K-V Pharmaceutical Company (KV), is an integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products. The Company focuses on women's health care products. It markets Evamist, a transdermal estrogen therapy delivering a low dose of estradiol in a once-daily spray indicated for the treatment of moderate-to-severe vasomotor symptoms due to menopause. Through Particle Dynamics, Inc. (PDI), which the Company has approved for divestiture, the Company has developed, manufactured and marketed technologically advanced, value-added raw material products for the pharmaceutical industry and other markets. On August 8, 2011, the Company sold Nesher Pharmaceuticals, Inc. (Nesher), the Company's wholly owned generic subsidiary, and the Company's generic business to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals (USA) LLC.

Receive KVPHQ News and Ratings via Email

Sign-up to receive the latest news and ratings for KVPHQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Lumara Health (OTCMKTS:KVPHQ) Frequently Asked Questions

What is Lumara Health's stock symbol?

Lumara Health trades on the OTCMKTS under the ticker symbol "KVPHQ."

Has Lumara Health been receiving favorable news coverage?

Press coverage about KVPHQ stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Lumara Health earned a news sentiment score of 1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Lumara Health?

Shares of KVPHQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Lumara Health?

Lumara Health's mailing address is 1100 Winter St Ste 3000, WALTHAM, MA 02451-1427, United States. The company can be reached via phone at +1-302-6587581.

MarketBeat Community Rating for Lumara Health (OTCMKTS KVPHQ)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about Lumara Health and other stocks. Vote "Outperform" if you believe KVPHQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KVPHQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel